Wednesday, June 10, 2026

Intelligence · Patents

Patents expiring in 2030

Annual patent cliff calendar for 2030 — US pharmaceutical patents by expiration date.

Patents
905

Quick answer

905 indexed pharmaceutical patents have expiration dates in 2030. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 7718387

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7718160

    Radiolabeled compounds and liposomes and their method of making and using same

    The Board of Regents of the University of Texas System · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7717728

    Electrical Connector

    Advanced Connectek Inc. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7718670

    Quinuclidine amide derivatives

    Laboratories Almirall, S.A. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7718769

    Tri-peptide hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7718196

    Rapamycin-resistant T cells and therapeutic uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7718610

    Retrocyclins: antiviral and antimicrobial peptides

    The Regents of the University of California · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7723512

    Oligonucleotides comprising a non-phosphate backbone linkage

    Alnylam Pharmaceuticals, Inc. · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7723432

    Method for the preparation of 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7723500

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7723300

    Regulators of the non-genomic action of progesterone and methods of use

    UNIVERSITY OF CONNECTICUT · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7723474

    Molecules that selectively home to vasculature of pre-malignant dysplastic lesions or malignancies

    The Regents of the University of California · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7723472

    Extracellular matrix binding chimeric proteins and methods of use thereof

    The Regents of the University of California · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7723496

    Preventives/remedies for cancer

    Takeda Pharmaceutical Company Limited · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. US 7722865

    Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7723375

    Metabolites of wortmannin analogs and methods of using the same

    Arizona Board of Regents, Acting on Behalf of the University of Arizona · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7723344

    Dipeptidyl peptidase inhibitors

    Takeda San Diego, Inc. · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7723322

    Fluoride carrier for positron emission tomography

    The Regents of the University of California · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7723317

    RNAi modulation of ApoB and uses thereof

    Alnylam Pharmaceuticals, Inc. · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7723311

    Delivery of bioactive substances to target cells

    United States of America as represented by the Secretary of the Air Force · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7723313

    Methods and compositions for inhibiting angiogenesis

    Northwestern University · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7723303

    Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response

    The Regents of the University of California · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7723104

    Cancer specific promoters

    The Board of Regents of the University of Texas System · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7723071

    DNA molecules encoding opioid receptors and methods of use thereof

    The Regents of the University of California · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7723022

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7723018

    Methods of assaying for cell cycle modulators using components of the ubiquitin ligation cascade

    Rigel Pharmaceuticals, Inc. · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7722898

    Modified-release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7722902

    Solid dosage form for providing a dietary supplement

    Sakura Properties, LLC · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7722862

    Regulatory T cells suppress autoimmunity

    The Regents of the University of California · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7723328

    Methods of facilitating cell survival using neurotrophin mimetics

    The Regents of the University of California · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7723111

    Activated dual specificity lymphocytes and their methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7723096

    Agonist peptides of carcinoembryonic antigen (CEA) and nucleic acid sequences encoding the agonist peptides

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7722889

    Plasmodium liver stage antigens

    The United States of America as represented by the Secretary of the Army · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. US 7723340

    Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith

    Pharmacopeia Drug Discovery, Inc. · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7723345

    Multicyclic amino acid derivatives and methods of their use

    LEXICON PHARMACEUTICALS, INC. · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7723470

    Glycopeptide derivatives and pharmaceutical compositions containing the same

    Theravance, Inc. · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7727534

    Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7727544

    Treatment of myopia

    The Regents of the University of California · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7728148

    Acyclic oximyl hepatitis C protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7727999

    Spiroazacyclic compounds as monoamine receptor modulators

    ACADIA Pharmaceuticals Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7728127

    Cross-linked glycopeptide-cephalosporin antibiotics

    Theravance, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7727554

    Sustained-release nanoparticle compositions and methods for using the same

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7728104

    Process for preparing glycopeptide phosphonate derivatives

    Theravance, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7728120

    EML4-ALK fusion gene

    CUREGENE K.K. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7728006

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7727542

    Bioactive materials, methods of making bioactive materials and method of use thereof

    UNIVERSITY OF CONNECTICUT · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7728004

    Crystalline form of a quinolinone-carboxamide compound

    Theravance, Inc. · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7727992

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 01 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 27 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2030?

905 published patents in our USPTO index have expiration dates falling in calendar year 2030.